HCMT
JAZZ icon

Highland Capital Management (Tennessee)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-28,450
Closed -$3.17M – 394
2024
Q3 		$3.17M Sell
28,450
-1,540
-5% -$169K 0.18% 137
2024
Q2 		$3.2M Sell
29,990
-2,480
-8% -$273K 0.19% 135
2024
Q1 		$3.91M Sell
32,470
-390
-1% -$47.8K 0.22% 122
2023
Q4 		$4.04M Buy
32,860
+250
+0.8% +$31.2K 0.25% 116
2023
Q3 		$4.22M Sell
32,610
-2,133
-6% -$284K 0.29% 99
2023
Q2 		$4.31M Sell
34,743
-560
-2% -$75.3K 0.28% 114
2023
Q1 		$5.17M Sell
35,303
-227
-0.6% -$33.6K 0.38% 75
2022
Q4 		$5.66M Sell
35,530
-280
-0.8% -$41K 0.4% 66
2022
Q3 		$4.77M Sell
35,810
-160
-0.4% -$24.3K 0.37% 72
2022
Q2 		$5.61M Sell
35,970
-580
-2% -$89.3K 0.4% 61
2022
Q1 		$5.69M Buy
+36,550
New +$5.3M 0.34% 84
2021
Q3 		– Sell
-23,050
Closed -$4.09M – 340
2021
Q2 		$4.09M Sell
23,050
-520
-2% -$90.1K 0.24% 120
2021
Q1 		$3.87M Sell
23,570
-2,020
-8% -$332K 0.24% 118
2020
Q4 		$4.22M Buy
+25,590
New +$3.81M 0.27% 107
2020
Q1 		– Sell
-12,702
Closed -$1.9M – 317
2019
Q4 		$1.9M Sell
12,702
-479
-4% -$65.2K 0.13% 163
2019
Q3 		$1.69M Buy
+13,181
New +$1.77M 0.13% 172
2019
Q2 		– Sell
-8,298
Closed -$1.19M – 326
2019
Q1 		$1.19M Buy
8,298
+971
+13% +$127K 0.09% 212
2018
Q4 		$908K Buy
+7,327
New +$1.09M 0.08% 216

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Highland Capital Management (Tennessee)'s JAZZ Position: Q4 2024 in Review

Highland Capital Management (Tennessee) sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2024, closing a stake of 28,450 shares — an estimated $3.17M sold.

Highland Capital Management (Tennessee) first reported a position in JAZZ in Q4 2018 and held it in 18 quarters. The position peaked at $5.69M in Q1 2022. 508 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

  • Highland Capital Management (Tennessee) reported no remaining Jazz Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 28,450 Jazz Pharmaceuticals shares in Q4 2024, an estimated $3.17M.
  • Highland Capital Management (Tennessee) first reported a position in Jazz Pharmaceuticals in Q4 2018 and held it in 18 quarters.
  • Highland Capital Management (Tennessee)'s Jazz Pharmaceuticals position peaked at $5.69M in Q1 2022.
  • 508 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2024, filed 23 Jan 2025.